Wang Wenying, Zheng Dedong, Li Huiya, Huang Jinhua, Chen Huijun, Ying Teng, Fang Jun, Luo Yukun
Department of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Heart Disease, Fuzhou, Fujian 350001, P.R. China.
Department of Hematology, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou, Fujian 350001, P.R. China.
Exp Ther Med. 2019 Mar;17(3):1847-1854. doi: 10.3892/etm.2018.7127. Epub 2018 Dec 21.
Cx43 has been documented to be involved in ischemic preconditioning (IPC). However, the participation of Cx43-formed hemichannels in IPC and the potential underlying mechanisms remain unclear. The present study focused on cardiomyocytes' volume regulation during IPC to investigate the role of hemichannels in the IPC-induced cardioprotection. In the study, mice cardiomyocytes were respectively treated with a hemichannel blocker, octanol or 18a-Glycyrrhizic acid (18a-GA), and a Cx43-silenced lentivirus. They were subsequently cultured in hypotonic solution to simulate ischemic reperfusion (SIR) and systemic ischemic preconditioning (SIP). Cell morphology and volumetric (area) change were detected by inverted microscopy at 30 min following the addition of hypotonic solution. Cardiomyocyte mortality was assessed by trypan blue stain assay. The analyses revealed that regardless of the treatments, hypotonic solution aggravated cell edema: Compared with the initial condition (the moment before the solution addition, 0 min), the volumetric area increased significantly 30 min later (for hypotonic+DMSO, 5,050±1,511 vs. 3,464±723 µm; for hypotonic+scramble lentiviral vector, 5,517±1,128 vs. 2,331±536 µm; P<0.05, respectively). Either treatment alleviated the edematous condition when a comparison was made between 30 min after the hypotonic addition and 0 min (for hypotonic+octanol, 2,990±765 vs. 2,821±773 µm; for hypotonic+18a-GA, 4,817±1,306 vs. 4,762±1,271 µm; for hypotonic+Cx43-silenced, 3,627±688 vs. 3,419±814 µm; P>0.05 for all). Notably, results indicated that the SIP group had lower mortality rates compared with its SIR counterpart; the hypotonic+octanol, hypotonic+18a-GA, and hypotonic+Cx43-silenced group showed markedly-declined mortality when compared with their respective control groups (respectively, 35.70±1.02, 30.76±2.20 vs. 53.58±2.14%; 30.89±2.37 vs. 54.12±2.55%; P<0.05 for all). The results suggest that ischemic preconditioning may provide cardioprotection by blocking the opening of the hemichannels and further mediating the volume regulation of cardiomyocytes.
已有文献证明Cx43参与缺血预处理(IPC)。然而,由Cx43形成的半通道在IPC中的参与情况及其潜在的作用机制仍不清楚。本研究聚焦于IPC期间心肌细胞的体积调节,以探讨半通道在IPC诱导的心脏保护中的作用。在该研究中,小鼠心肌细胞分别用半通道阻滞剂辛醇或18α-甘草酸(18α-GA)以及Cx43沉默慢病毒进行处理。随后将它们置于低渗溶液中培养以模拟缺血再灌注(SIR)和全身缺血预处理(SIP)。在加入低渗溶液后30分钟,通过倒置显微镜检测细胞形态和体积(面积)变化。通过台盼蓝染色法评估心肌细胞死亡率。分析显示,无论何种处理,低渗溶液都会加重细胞水肿:与初始状态(加入溶液前的时刻,0分钟)相比,30分钟后体积面积显著增加(低渗+二甲基亚砜组,5050±1511对3464±723µm;低渗+乱序慢病毒载体组,5517±1128对2331±536µm;P均<0.05)。当比较低渗溶液加入后30分钟和0分钟时,任何一种处理都减轻了水肿状态(低渗+辛醇组,2990±765对2821±773µm;低渗+18α-GA组,4817±1306对4762±1271µm;低渗+Cx43沉默组,3627±688对3419±814µm;所有P>0.05)。值得注意的是,结果表明SIP组的死亡率低于其SIR对应组;低渗+辛醇组、低渗+18α-GA组和低渗+Cx43沉默组与各自的对照组相比,死亡率显著下降(分别为35.70±1.02、30.76±2.20对53.58±2.14%;30.89±2.37对54.12±2.55%;所有P<0.05)。结果表明,缺血预处理可能通过阻断半通道的开放并进一步介导心肌细胞的体积调节来提供心脏保护。